Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Cash from Investing Activities: 2018-2024

Historic Cash from Investing Activities for Verastem (VSTM) over the last 5 years, with Jun 2024 value amounting to $29.0 million.

  • Verastem's Cash from Investing Activities was N/A to $29.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $72.2 million, marking a year-over-year change of. This contributed to the annual value of $60.0 million for FY2024, which is 234.93% up from last year.
  • According to the latest figures from Q2 2024, Verastem's Cash from Investing Activities is $29.0 million, which was down 6.41% from $31.0 million recorded in Q1 2024.
  • Verastem's 5-year Cash from Investing Activities high stood at $32.0 million for Q1 2020, and its period low was -$79.4 million during Q4 2020.
  • Moreover, its 3-year median value for Cash from Investing Activities was $19.3 million (2022), whereas its average is $17.9 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 415.93% in 2020, then skyrocketed by 166,766.67% in 2021.
  • Verastem's Cash from Investing Activities (Quarterly) stood at -$79.4 million in 2020, then skyrocketed by 100.08% to $66,000 in 2021, then skyrocketed by 19,634.85% to $13.0 million in 2022, then crashed by 104.17% to -$804,000 in 2023, then spiked by 3,953.11% to $29.0 million in 2024.
  • Its Cash from Investing Activities stands at $29.0 million for Q2 2024, versus $31.0 million for Q1 2024 and -$804,000 for Q1 2023.